AI for Life Sciences & Healthcare
Drug and device makers, hospitals, health systems and payers need AI that clinicians trust and quality and compliance teams can approve. For providers and payers we deliver clinical decision support, care operations and revenue-cycle AI. For life sciences companies we deliver AI for clinical trials, drug safety, manufacturing quality and AI-enabled devices. All of it comes with the validation, privacy and record-keeping the sector requires, and we stay to monitor it in use.

Where AI pays off in life sciences & healthcare.
8 focus areas. Each has a sourced brief: what decides whether it pays off, the rules that apply, where it goes wrong and how to measure it.
Hospitals, health systems and payers
01
Clinical decision support
Models and assistants that support clinicians at the point of care, validated against clinical outcomes and reviewed by clinical governance.
Read the brief, 7 sources02
Care operations and capacity
Forecasting and scheduling for beds, staff and operating rooms, integrated with the systems your operations teams already use.
Read the brief, 7 sources03
Revenue cycle and claims
Coding assistance, prior authorization packets and denial management, with a person signing off every code and adverse decision, so yield improves without compliance exposure.
Read the brief, 10 sources04
Patient engagement
Patient-facing assistants and outreach with consent, privacy and escalation to a human designed in from the start.
Read the brief, 10 sources
Drug and device makers
05
Clinical trials and development
Protocol feasibility, patient matching, central monitoring and trial documents, validated for each use and kept inspection-ready under good clinical practice.
Read the brief, 8 sources06
Pharmacovigilance and drug safety
Adverse event intake, case processing, literature screening and signal detection, automated with human review and built to keep every reporting deadline.
Read the brief, 8 sources07
Manufacturing and quality
Process monitoring, visual inspection, deviation triage and batch record review for GMP sites, validated as computerized systems with records inspectors can follow.
Read the brief, 8 sources08
AI-enabled medical devices
AI software that is itself a medical device, built with design controls, sequestered test data, a change control plan for model updates and monitoring after clearance.
Read the brief, 8 sources
One team for life sciences & healthcare, across every practice.
Most engagements start with a senior advisor inside your leadership team. Each practice then fields a team built for this sector.
Clinical AI validation, validated and auditable records, and HIPAA-aligned privacy and security assurance.
Every engagement in this sector is scoped against the rules that apply to it, and the evidence is produced as the work happens rather than assembled afterwards.
Rules we scope against
- HIPAA
- FDA 21 CFR Part 11 electronic records and signatures
- ICH E6(R3) Good Clinical Practice
- 21 CFR 314.80 safety reporting
- FDA Quality Management System Regulation (21 CFR Part 820)
- EU GMP Annex 22 on AI (draft)
- FDA Clinical Decision Support guidance (2026)
- HHS Section 1557 nondiscrimination
- CMS prior authorization rule (CMS-0057-F)
- ONC HTI-5 (decision support transparency removed from Dec 2026)
- TCPA for patient outreach
Other industries
- Financial Services & Capital MarketsRisk models, compliance automation and fraud detection built to pass the strictest model governance in any industry.
- Utilities & EnergyAI for grid operations, asset maintenance and customer operations, with the safety and compliance controls operational technology requires.
- Telecom, Media, Entertainment & GamingNetwork optimization, personalization and streaming reliability at the scale telecoms, studios and game publishers operate.